Morphic Therapeutic

1 follower


Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.

Industries

Headquarters

Stage

Employees

Links

Org chart

Praveen Tipirneni
President & CEO

Praveen Tipirneni

Collapse
Bruce Rogers
Chief Scientific Officer
William DeVaul
General Counsel & Secretary
Aaron Pelta
Senior Vice President, Corporate Business Development
Chris Erdman
Senior Vice President, Investor Relations & Corporate Communications
Joanne Gibbons
SVP, Regulatory & Quality
Hanh Nguyen
SVP, Technical Operations
Brihad Abhyankar
Vice President, Clinical Development
Carolyn Soo
Vice President, Clinical Operations
Matt Bursavich
VP, Chemical Sciences
Jeff Handler
Vice President, Safety Assessment
Blaise Lippa
Head of Chemistry